Detalles de la búsqueda
1.
Twice-Daily Dolutegravir Based Antiretroviral Therapy with One Month of Daily Rifapentine and Isoniazid (1HP) for TB Prevention.
Clin Infect Dis
; 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38568956
2.
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
N Engl J Med
; 384(18): 1705-1718, 2021 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33951360
3.
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349).
Clin Infect Dis
; 76(3): e580-e589, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36041016
4.
Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine.
Clin Infect Dis
; 75(4): 560-566, 2022 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34918028
5.
Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis.
Pharmacogenet Genomics
; 32(1): 24-30, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34369424
6.
Population Pharmacokinetic Modeling and Simulation of Rifapentine Supports Concomitant Antiretroviral Therapy with Efavirenz and Non-Weight Based Dosing.
Antimicrob Agents Chemother
; 66(9): e0238521, 2022 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35943252
7.
Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial.
Lancet
; 395(10231): 1195-1207, 2020 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32145827
8.
Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial.
J Infect Dis
; 222(Suppl 1): S20-S30, 2020 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32645159
9.
Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing Frequency.
Clin Infect Dis
; 71(3): 517-524, 2020 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31504342
10.
A Parsimonious Host Inflammatory Biomarker Signature Predicts Incident Tuberculosis and Mortality in Advanced Human Immunodeficiency Virus.
Clin Infect Dis
; 71(10): 2645-2654, 2020 12 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31761933
11.
As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial.
Clin Infect Dis
; 67(2): 251-260, 2018 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29365083
12.
Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study.
BMC Med
; 16(1): 161, 2018 09 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-30244671
13.
Quality of life among HIV-infected individuals failing first-line antiretroviral therapy in resource-limited settings.
AIDS Care
; 30(8): 954-962, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29343078
14.
Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained Settings.
J Infect Dis
; 213(7): 1074-8, 2016 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26621909
15.
Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation.
Clin Infect Dis
; 61(1): 102-10, 2015 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25828994
16.
Differences in antiretroviral safety and efficacy by sex in a multinational randomized clinical trial.
HIV Clin Trials
; 16(3): 89-99, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25979186
17.
Monocyte to lymphocyte ratio and hemoglobin level to predict tuberculosis after antiretroviral therapy initiation.
AIDS
; 38(1): 31-38, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37696248
18.
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group.
PLoS One
; 18(2): e0281580, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36780493
19.
Incidence and Predictors of Pregnancy in Women Enrolled in Large Multinational HIV Treatment Trials of the AIDS Clinical Trials Group.
J Acquir Immune Defic Syndr
; 94(5): 461-467, 2023 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37820116
20.
Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings.
J Acquir Immune Defic Syndr
; 94(2): 165-173, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37368929